Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture

Toxicology

Volumn 133, Issue 2-3, 1999, Pages 159-169

  Fujiwara, Yasuyuki ^a   Kaji, Toshiyuki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Endothelial cell; Fibroblast growth factor; Heparan sulfate; Lead; Perlecan; Proteoglycan

Indexed keywords

PERLECAN; PROTEOGLYCAN;

ANIMAL CELL; AORTA; ARTICLE; CATTLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; LEAD POISONING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; CATTLE; CELL DIVISION; CELLS, CULTURED; CHONDROITIN ABC LYASE; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; GLUCOSAMINE; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; LEAD; MOLECULAR WEIGHT; PROTEIN SYNTHESIS INHIBITORS; PROTEOGLYCANS; SULFATES; SULFUR RADIOISOTOPES; TRITIUM;

EID: 0033010969     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00027-X     Document Type: Article

References (48)

1. Assoian R.K., Sporn M.B. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102:1986;1217-1223.
2. Aviezer D., Hecht D., Safran M., Eisinger M., David G., Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis. Cell. 79:1994;1005-1013.
3. Aviezer D., Levy E., Safran M. et al. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 269:1994;114-121.
4. Campbell G.R., Campbell J.H. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp. Mol. Pathol. 42:1985;139-162.
5. Connolly D.T., Heuvelman D.M., Nelson R. et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1989;1470-1478.
6. Dingwall-Fordyce I., Lane R.E. A follow-up study of lead workers. Br. J. Ind. Med. 20:1963;313-315.
7. Fischer G.M., Swain M.L., Cherian K. Increased vascular collagen and elastin synthesis in experimental atherosclerosis in the rabbit. Variation in synthesis among major vessels. Atherosclerosis. 35:1980;11-20.
8. Flaumenhaft R., Moscatelli D., Saksela O., Rifkin D.B. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J. Cell. Physiol. 140:1989;75-81.
9. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
10. Frater-Schröder M., Müller G., Birchmeier W., Böhlen P. Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun. 137:1986;295-302.
11. Fujiwara Y., Kaji T. Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis. Toxicology. 133:1999;147-157.
12. Fujiwara Y., Kaji T., Sakurai S., Sakamoto M., Kozuka H. Inhibitory effect of lead on the repair of wounded monolayers of cultured vascular endothelial cells. Toxicology. 117:1997;193-198.
13. Gill P.J., Adler J., Silbert C.K., Silbert J.E. Removal of glycosaminoglycans from cultures of human skin fibroblasts. Biochem. J. 194:1981;299-307.
14. Hannan R.L., Kourembanas S., Flanders K.C. et al. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors. 1:1988;7-17.
15. Hascall V., Kimura J.H. Proteoglycans: isolation and characterization. Methods Enzymol. 82:1982;769-800.
16. Hein M., Fischer J., Kim D.K., Hein L., Pratt R.E. Vascular smooth muscle cell phenotype influences glycosaminoglycan composition and growth effects of extracellular matrix. J. Vasc. Res. 33:1996;433-441.
17. Hildebrand A., Romaris M., Rasmussen L.M. et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302:1994;527-534.
18. Iozzo R.V., Cohen I.R., Grassel S., Murdoch A.D. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302:1994;625-639.
19. Järveläinen H.T., Kinsella M.G., Wight T.N., Sandell L.J. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J. Biol. Chem. 266:1991;23274-23281.
20. Järveläinen H.T., Truela-Arispe M.L., Kinsella M.G., Sandell L.J., Sage E.H., Wight T.N. Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp. Cell Res. 203:1992;395-401.
21. Kaji T., Yamamoto C., Sakamoto M. Effect of lead on the glycosaminoglycans metabolism of bovine aortic endothelial cells in culture. Toxicology. 68:1991;249-257.
22. Kaji T., Yamamoto C., Sakamoto M., Kozuka H. Inhibitory effect of lead on the release of tissue plasminogen activator from human vascular endothelial cells in culture. Toxicology. 73:1992;219-227.
23. Kaji T., Fujiwara Y., Hoshino M., Yamamoto C., Sakamoto M., Kozuka H. Inhibitory effect of lead on the proliferation of cultured vascular endothelial cells. Toxicology. 95:1995;87-92.
24. Kaji T., Ohkawara S., Nakajima M. et al. Lead-induced alteration of heparan sulfate proteoglycans in cultured vascular endothelial cells. Toxicology. 118:1997;1-10.
25. Kinsella M.G., Wight T.N. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J. Cell Biol. 102:1986;679-687.
26. Kinsella M.G., Tsoi C.K., Järveläinen H.T., Wight T.N. Selective expression and processing of biglycan during migration of bovine aortic endothelial cells. J. Biol. Chem. 272:1997;318-325.
27. Kissane J.M., Robins E. The fluorometric measurement of deoxyribonucleic acid in animal tissue with special reference to the central nervous system. J. Biol. Chem. 233:1958;184-188.
28. Kojima T., Shworak N.W., Rosenberg R.D. Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from rat endothelial cell line. J. Biol. Chem. 267:1992;4870-4877.
29. Ladoux A., Frelin C. Expression of vascular endothelial growth factor by cultured endothelial cells from bovine microvessels. Biochem. Biophys. Res. Commun. 194:1993;799-803.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 277:1970;680-685.
31. 2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets. Biochem. Pharmacol. 38:1989;1841-1847.
32. Mertens G., Cassiman J.J., Van den Berghe H., Vermylen J., David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells: core protein characterization and antithrombin III binding properties. J. Biol. Chem. 267:1992;20435-20443.
33. Morita H., Takeuchi T., Suzuki S. et al. Aortic endothelial cells synthesized a large chondroitin sulfate proteoglycan capable of binding to hyaluronate. Biochem. J. 265:1990;61-68.
34. Morris T.E., Mattox P.A., Shipley G.D., Wagner C.R., Hosenpud J.D. The pattern of cytokine messenger RNA expression in human aortic endothelial cells is different from that of human umbilical vein endothelial cells. Transpl. Immunol. 1:1993;137-142.
35. Oohira A., Wight T.N., Bornstein P. Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J. Biol. Chem. 258:1983;2014-2021.
36. Presta M., Maier J.A.M., Rusnati M., Raghotti G. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biological active form. J. Cell. Physiol. 140:1989;68-74.
37. Revis N.W., Zinsmeister A.R., Bull R. Atherosclerosis and hypertension induced by lead and cadmium ions: an effect prevented by calcium ion. Proc. Natl. Acad. Sci. USA. 78:1981;6494-6498.
38. Rifkin D.B., Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1989;1-6.
39. Roberts A.B., Sporn M.B. Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta. Am. Rev. Respir. Dis. 140:1989;1126-1128.
40. Ross R., Raines E.W., Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169.
41. Saksela O., Moscatelli D., Sommer A., Rifkin D.B. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107:1988;734-751.
42. Sato Y., Rifkin D.B. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell Biol. 107:1988;1199-1205.
43. Wasteson Å. Method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulfate. J. Chromatogr. 59:1971;87-97.
44. Wasteson Å., Uthne K., Westermark B. A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells. Biochem. J. 136:1973;1069-1074.
45. Weiser M.C., Belknap J.K., Grieshaber S.S., Kinsella M.G., Majack R.A. Developmental regulation of perlecan gene expression in aortic smooth muscle cells. Matrix Biol. 15:1996;331-340.
46. Wight T.N. Vessel proteoglycans and thrombogenesis. Prog. Hemost. Thromb. 5:1980;1-39.
47. Wight T.N., Ross R. Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima. J. Cell Biol. 67:1975;660-674.
48. Woost P.G., Jumblatt M.M., Eiferman R.A., Schultz G.S. Growth factors and corneal endothelial cells. I. Stimulation of bovine corneal endothelial cell DNA synthesis by defined growth factors. Cornea. 11:1992;1-10.